Greenwich LifeSciences (GLSI)
Runs a single Phase III trial for a peptide vaccine preventing HER2-positive breast cancer recurrence.
$15.68
Pre-market−0.11 (−0.70%)
At close$15.79(+5.20%)
Something off on this page? Send us feedback.
Next report
Nov 13, 2026
estimated · in 71 days
EPS estimate
−$0.34
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Nov '24Apr '25May '25Aug '25Nov '25Jun '26Aug '26Nov '26
Reported−$0.20−$0.61−$0.25−$0.30−$0.30−$0.39−$0.27Pending
Estimate−$0.21−$0.21−$0.24−$0.24−$0.30−$0.33−$0.33−$0.34
Surprise+4.8%−190.5%−4.2%−25.0%0.0%−18.2%+18.2%—
RevenueReportedEstimate
Nov '24Apr '25May '25Aug '25Nov '25Jun '26Aug '26Nov '26
Reported—$3.6K—————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.34 | — | — |
| Aug 2026 | −$0.33 | −$0.27 | +18.2% |
| Jun 2026 | −$0.33 | — | — |
| Jun 2026 | −$0.33 | −$0.39 | −18.2% |
| Jun 2026 | −$0.33 | — | — |
| Jun 2026 | −$0.33 | — | — |
| Mar 2026 | −$0.32 | — | — |
| Nov 2025 | −$0.30 | −$0.30 | 0.0% |
| Aug 2025 | −$0.24 | −$0.30 | −25.0% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Sep 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$0.34 | — | — | — | — | — | — |
| Aug 11, 2026 | −$0.33 | −$0.27 | +18.2% | — | — | — | +0.3% |
| Jun 9, 2026 | −$0.33 | — | — | — | — | — | — |
| Jun 3, 2026 | −$0.33 | −$0.39 | −18.2% | — | — | — | −2.6% |
| Jun 2, 2026 | −$0.33 | — | — | $3.6K | — | — | — |
| Jun 1, 2026 | −$0.33 | — | — | — | — | — | — |
| Mar 31, 2026 | −$0.32 | — | — | — | — | — | — |
| Nov 14, 2025 | −$0.30 | −$0.30 | 0.0% | — | — | — | −1.1% |
| Aug 14, 2025 | −$0.24 | −$0.30 | −25.0% | — | — | — | +0.8% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||||||
| May 20, 2025 | |||||||
| Apr 15, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 20, 2024 | |||||||
| Apr 15, 2024 | |||||||
| Oct 19, 2023 | |||||||
| Aug 21, 2023 | |||||||
| May 22, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 20, 2022 | |||||||
| Mar 21, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 13, 2021 | |||||||
| May 20, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Sep 28, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||